RxDoctor Payments Data

William Orton, PA

Physician Assistant · Beaufort, NCNPI 1518019413

Payments from drug & device makers

$1,001in general payments, 2019–2025

Across 55 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$132
  • AbbVie$119
  • Amgen$88
  • AstraZeneca$79
  • Pfizer$76
  • Takeda Pharmaceuticals U.S.A., Inc.$62
  • plus $445 from 15 others

What the payments were for

  • Food & beverage$1,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,001 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$47,961
Medicare patients
109
Services billed
700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$50,133
JardianceEmpagliflozin30$25,366
FarxigaDapagliflozin Propanediol25$23,007
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$15,707
EliquisApixaban13$14,980
MounjaroTirzepatide12$13,672
SymbicortBudesonide/Formoterol Fumarate31$7,014
Combivent RespimatIpratropium/Albuterol Sulfate11$5,164
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$2,975
Gabapentin106$2,372
Omeprazole121$2,085
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,036
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$1,697
Celecoxib45$1,646
Atorvastatin Calcium142$1,412

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$52$50,13331 claims
Boehringer IngelheimJardiance, Combivent Respimat$35$30,53141 claims
AstraZenecaFarxiga, Symbicort$79$30,02156 claims
PfizerEliquis$76$14,98013 claims
Lilly USA, LLCMounjaro$132$13,67212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Beaufort

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →